Healthcare entity
medical-devices is the sole category represented across all 1 tracked stories. Genetic Signatures is most often covered alongside Anne Lockwood, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 4 original sources each against 4.7 for the same window.
Last mentioned: Feb 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
medical-devices is the sole category represented across all 1 tracked stories. Genetic Signatures is most often covered alongside Anne Lockwood, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 4 original sources each against 4.7 for the same window. At 5, the average consequence score sits below the same-window beat average of 5.6. We currently track 1 Healthcare story that mention Genetic Signatures, all published on February 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Genetic Signatures. Shared-story counts are live from our verified record — not editorial picks.
GSS Restructuring Signal
GSS board announces steps to address unsustainable cash burn levels.
H1 FY26 Earnings Calls
Genetic Signatures and ClearView Wealth release half-year results.
Zurich Acquisition Announcement
ClearView Wealth enters into a Scheme Implementation Deed with Zurich.
Genetic Signatures (ASX:GSS) reported a modest revenue increase for H1 FY26 but warned of unsustainable cash burn and declining gross margins. The company is now pivoting toward aggressive cost-cutting and operational restructuring to stabilize its financial position.
Source: Bbns · Daily Political
Genetic Signatures is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
